@BaimInstitute

Baim Institute for Clinical Research is a leading, not-for-profit ARO that delivers insight, innovation and leadership in today's dynamic research environment

 Boston, MA
baiminstitute.org/
Joined September 2009
  • Tweets2.2K
  • Following844
  • Followers1.4K
309Media
RT @CMichaelGibson: Baim Institute Launches HOLISTIC Trial to Improve Kidney and Heart Outcomes in Patients With Chronic Kidney Disease and…
2
3
Correction to: Development and Validation of the American Heart Association's PREVENT Equations. doi.org/10.1161/cir.00000000… Contributions from Baim faculty, @RangaswJ and @KatherineTuttl8. #BaimInstitute #ClinicalResearch

Correction to: Development and Validation of the American Heart Association’s PREVENT Equations |...

ahajournals.org
1
93
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026). doi.org/10.1016/j.jacc.2026.… Contributions from Baim faculty, @lamcardio and @akshaydesaimd. #BaimInstitute #ClinicalResearch #Cardiology #HeartFailure
1
1
102
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes. doi.org/10.1038/s41581-026-0… Contributions from Baim faculty, @KatherineTuttl8. #BaimInstitute #ClinicalResearch

Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes

Nature Reviews Nephrology - Chronic kidney disease (CKD) is characterized by a pro-inflammatory state that contributes to kidney damage, atherosclerosis and cardiac dysfunction. This Review...

nature.com
2
3
195
Capillary-selective vasodilation through myosin inhibition halts ischaemic cascades. doi.org/10.1038/s41586-026-1… Contributions from Baim President & CEO, @CMichaelGibson. #BaimInstitute #ClinicalResearch #Cardiology

Capillary-selective vasodilation through myosin inhibition halts ischaemic cascades

Nature - R(+)2501 reverses capillary no-reflow by relaxing pericytes, restoring microvascular perfusion and improving survival in animal models of myocardial infarction and acute kidney injury.

nature.com
1
3
390
Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysis. doi.org/10.1093/eurjpc/zwag4… Contributions from Baim faculty, @ProfSNicholls, @LincoffMichael and Dr. Darren McGuire.

Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure...

AbstractAims. The impact of tirzepatide and dulaglutide on major adverse cardiovascular events (MACE) and heart failure (HF) outcomes according to HF statu

academic.oup.com
1
122
Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome. doi.org/10.1016/j.ajpc.2026.… Contributions from Baim faculty, @gabrielsteg and Dr. Harvey white. #BaimInstitue #Cardiology
1
3
131
Disease modification outcomes in type 2 diabetes: a modified Delphi. doi.org/10.1016/s2213-8587(2… Contributions from Baim faculty, @JavedButler1 and Dr. Leigh Perreault. #BaimInstitute #ClinicalResearch #T2D
81
Expanded Results From a Dedicated Guideline-Directed Medical Therapy Clinic. doi.org/10.1016/j.cardfail.2… Contributions from Baim CMO, Dr. James Januzzi. #BaimInstitute #ClinicalResearch
1
1
58
Implications of Serum Transthyretin to NT-proBNP Ratio in Transthyretin Amyloid Cardiomyopathy: Insights From ATTRibute-CM. doi.org/10.1016/j.jchf.2026.… Contributions from Baim President & CEO, @CMichaelGibson and Baim CSO, Dr. James Januzzi. #BaimInstitute #ClinicalResearch
2
6
513
Diagnostic Accuracy of NT-proBNP thresholds in Dyspneic Patients in the Emergency Department according to patients' characteristics: A Systematic Review and Meta-Analysis. doi.org/10.1093/ejhf/xuag314 Contributions from Baim CSO, Dr. James Januzzi. #BaimInstitute #ClinicalResearch

Diagnostic Accuracy of NT-proBNP thresholds in Dyspneic Patients in the Emergency Department...

AbstractBackground. Concentrations of N-terminal pro-B type natriuretic peptide (NT-proBNP) is central to acute heart failure (AHF) diagnosis in dyspneic e

academic.oup.com
1
1
1
70
The recording from today's Baim Grand Rounds with @EricSecemskyMD on "The Future of Managing Uncontrolled Hypertension: The Re-Emergence of Renal Denervation" is now available on the Baim website. You can find it here: baiminstitute.org/index.php/…
5
8
19
3,045
Reminder! Join us in 30 minutes at 9:30 am ET for Baim Grand Rounds with @EricSecemskyMD, presenting “The Future of Managing Uncontrolled Hypertension: The Re-Emergence of Renal Denervation." Zoom link: us06web.zoom.us/j/8141542979…
10
17
1,696
Associations of Mild or Trace Valvular Abnormalities With Cardiac Remodeling in Older Adults: The ARIC Study. doi.org/10.1161/jaha.126.049… Contributions from Baim faculty, @CBallantyneMD and @scottdsolomon. #BaimInstitute #ClinicalResearch #Cardiology

Associations of Mild or Trace Valvular Abnormalities With Cardiac Remodeling in Older Adults: The...

ahajournals.org
1
3
227
Clarifying the Clinical Relevance of V Waves. doi.org/10.1161/circulationa… Contributions from Baim faculty, @EricSecemskyMD. #BaimInstitute #ClinicalResearch #Cardiology

Clarifying the Clinical Relevance of V Waves | Circulation

ahajournals.org
1
101
Temporary mechanical circulatory support in cardiogenic shock. doi.org/10.1093/eurheartj/eh… Contributions from Baim faculty, @VijayKunadian and @VranckxPascal. #BaimInstitute #ClinicalResearch #Cardiology

Temporary mechanical circulatory support in cardiogenic shock: A clinical consensus statement of...

Abstract. Cardiogenic shock (CS) remains a heterogeneous syndrome associated with persistently high mortality despite advances in temporary mechanical circ

academic.oup.com
77
From Rescue to Interception: The PREVENT 2-LATE (PReserve Eligibility Via Early, Necessary Transfer) Framework for Advanced Heart Failure. doi.org/10.1016/j.cardfail.2… Contributions from Baim faculty, Dr. Mandeep Mehra and @akshaydesaimd. #BaimInstitute #ClinicalResearch
3
99
Heart Failure With Improved Ejection Fraction: What Does "Improved" Mean in Women vs Men? doi.org/10.1016/j.jchf.2026.… Contributions from Baim faculty, @lamcardio. #BaimInstitute #ClinicalResearch #Cardiology #HeartFailure
1
74
Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II. doi.org/10.1016/j.jchf.2026.… Contributions from Baim CMO, @DonaldCutlip and Baim faculty, @scottdsolomon. #BaimInstitute #ClinicalResearch
2
159
Beyond the visual estimate: standardising device success after PCI. doi.org/10.4244/eij-d-26-010… Contributions from Baim CMO, @DonaldCutlip. #BaimInstitute #ClinicalResearch #Cardiology

Beyond the visual estimate: standardising device success after PCI

Study comparing methods for evaluating device success in coronary stent trials and their association with clinical outcomes.

eurointervention.pcronline.com
2
77
Load more